Cyhoeddiadau 2022

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

Allen, L. , Shrikrishnapalasuriyar, N. and Rees, D. A. 2022. Long-term health outcomes in young women with Polycystic Ovary Syndrome: a narrative review. Clinical Endocrinology 97 (2), pp.187-198. (10.1111/cen.14609)
Alsaqati, M. et al. 2022. NRSF/REST lies at the intersection between epigenetic regulation, miRNA-mediated gene control and neurodevelopmental pathways associated with Intellectual disability (ID) and Schizophrenia. Translational Psychiatry 12 438. (10.1038/s41398-022-02199-z)
Bailey, G. A. , Martin, E. and Peall, K. J. 2022. Cognitive and neuropsychiatric impairment in dystonia. Current Neurology and Neuroscience Reports 22 , pp.699-708. (10.1007/s11910-022-01233-3)
Bailey, G. A. et al. 2022. Longitudinal analysis of the relationship between motor and psychiatric symptoms in idiopathic dystonia. European Journal of Neurology 29 (12), pp.3513-3527. (10.1111/ene.15530)
Brcic, L. et al., 2022. Comorbid medical issues in X-linked ichthyosis [Letter]. JID Innovations 2 (3) 100109. (10.1016/j.xjidi.2022.100109)
Broom, E. et al. 2022. Recruitment of frontal-sensory circuits during visual discrimination. Cell Reports 39 (10) 110932. (10.1016/j.celrep.2022.110932)
Chapman, G. et al. 2022. Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome. Molecular Psychiatry 27 , pp.819-830. (10.1038/s41380-021-01182-2)
Clifton, N. et al. 2022. Developmental disruption to the cortical transcriptome and synaptosome in a model of SETD1A loss-of-function. Human Molecular Genetics 31 (18), pp.3095-3106. (10.1093/hmg/ddac105)
Clutterbuck, R. A. , Livingston, L. A. and Shah, P. 2022. The Four-Item Mentalising Index (FIMI) is a valid, reliable, and practical way to assess mentalising: Reply to Murphy et al. (2022). Psychological Assessment 34 , pp.405-408. (10.1037/pas0001120)
Cruz Santos, M. , Fernandez Cardo, L. and Li, M. 2022. A novel LHX6 reporter cell line for tracking human iPSC-derived cortical interneurons. Cells 11 (5) 853. (10.3390/cells11050853)
Daughters, K. et al. 2022. Oxytocin administration versus emotion training in healthy males: Considerations for future research. Philosophical Transactions of the Royal Society B: Biological Sciences 377 (1858) 20210056. (10.1098/rstb.2021.0056)
Daughters, K. , Rees, A. and Unwin, K. 2022. ODP365 The psychological impact of adult-onset craniopharyngioma: the experience of patients and clinicians. Journal of the Endocrine Society 6 (S1) A516. (10.1210/jendso/bvac150.1073)
Donnelly, N. A. et al., 2022. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms. eLife 11 e75482. (10.7554/elife.75482)
Griesius, S. et al., 2022. Reduced expression of the psychiatric risk gene DLG2 (PSD93) impairs hippocampal synaptic integration and plasticity. Neuropsychopharmacology 47 , pp.1367-1378. (10.1038/s41386-022-01277-6)
Hall, J. and Bray, N. J. 2022. Schizophrenia genomics: convergence on synaptic development, adult synaptic plasticity, or both?. Biological Psychiatry 91 (8), pp.709-717. (10.1016/j.biopsych.2021.10.018)
Hamshere, M. L. et al. 2022. Embedding genomic research into teaching practice: the rewards and potential pitfalls. Genetics Society News 87 , pp.30-31.
MacIver, C. L. et al. 2022. Structural magnetic resonance imaging in dystonia: A systematic review of methodological approaches and findings. European Journal of Neurology 29 (11), pp.3418-3448. (10.1111/ene.15483)
Moon, A. L. et al. 2022. Social interaction following prepubertal stress alters prefrontal gene expression associated with cell signalling and oligodendrocytes. Translational Psychiatry 12 (1) 516. (10.1038/s41398-022-02280-7)
Morella, I. et al. 2022. Nicotine self-administration and ERK signaling are altered in RasGRF2 knockout mice. Frontiers in Pharmacology 13 986566. (10.3389/fphar.2022.986566)
Morella, I. M. , Brambilla, R. and Morè, L. 2022. Emerging roles of brain metabolism in cognitive impairment and neuropsychiatric disorders. Neuroscience & Biobehavioral Reviews 142 104892. (10.1016/j.neubiorev.2022.104892)
Mustafa, M. and Zaben, M. 2022. Minimal invasive brain surgery for epilepsy; can it be the future?. Journal of Neurology 269 (11), pp.6178-6180. (10.1007/s00415-022-11360-z)
Namkung, H. et al., 2022. Parsing neural circuits of fear learning and extinction across basic and clinical neuroscience: Towards better translation. Neuroscience and Biobehavioral Reviews 134 104502. (10.1016/j.neubiorev.2021.12.025)
Ooi, S. Z. Y. et al. 2022. Interleukin-6 as a prognostic biomarker of clinical outcomes after traumatic brain injury: a systematic review. Neurosurgical Review 45 , pp.3035-3054. (10.1007/s10143-022-01827-y)
Palmer, D. et al., 2022. Exome sequencing in bipolar disorder reveals AKAP11 as a risk gene shared with schizophrenia. Nature Genetics (10.1038/s41588-022-01034-x)
Pass, R. et al. 2022. Selective behavioural impairments in mice heterozygous for the cross disorder psychiatric risk gene DLG2. Genes, Brain and Behavior 21 (4) e12799. (10.1111/gbb.12799)
Pérez-Dueñas, B. et al., 2022. The genetic landscape of complex childhood-onset hyperkinetic movement disorders. Movement Disorders 37 (11), pp.2197-2209. (10.1002/mds.29182)
Perros, P. et al., 2022. Post-radioiodine Graves' management: the PRAGMA study. Clinical Endocrinology 97 (5), pp.664-675. (10.1111/cen.14719)
Sanders, B. et al. 2022. Transcriptional programs regulating neuronal differentiation are disrupted in DLG2 knockout human embryonic stem cells and enriched for schizophrenia and related disorders risk variants. Nature Communications 13 (1) 27. (10.1038/s41467-021-27601-0)
Scott, F. et al., 2022. Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery. Bioorganic and Medicinal Chemistry Letters 60 128588. (10.1016/j.bmcl.2022.128588)
Shepherd, F. and Davies, W. 2022. An update on the presentation, nosology, and causes of postpartum psychosis. Psychiatric Times 39 (6), pp.23-25.
Silva, A. I. et al. 2022. Neuroimaging findings in neurodevelopmental copy number variants: identifying molecular pathways to convergent phenotypes. Biological Psychiatry 92 (5), pp.341-361. (10.1016/j.biopsych.2022.03.018)
Taylor, E. C. et al., 2022. Rethinking fast and slow processing in autism. Journal of Psychopathology and Clinical Science 131 (4), pp.392-406. (10.1037/abn0000734)
Underwood, J. et al. 2022. Neurological and psychiatric disorders among autistic adults: a population healthcare record study. Psychological Medicine (10.1017/S0033291722002884)
Underwood, J. F. G. et al. 2022. Evidence of increasing recorded diagnosis of autism spectrum disorders in Wales, UK – an e-cohort study. Autism 26 (6), pp.1499-1508. (10.1177/13623613211059674)
Wadon, M. et al. 2022. Clinical and genotypic analysis in determining dystonia non-motor phenotypic heterogeneity: a UK Biobank study. Journal of Neurology 269 , pp.6436-6451. (10.1007/s00415-022-11307-4)
Westacott, L. and Wilkinson, L. 2022. Complement dependent synaptic reorganisation during critical periods of brain development and risk for psychiatric disorder. Frontiers in Neuroscience 16 840266. (10.3389/fnins.2022.840266)
Wolstencroft, J. et al., 2022. Neuropsychiatric risk in children with intellectual disability of genetic origin: IMAGINE, a UK national cohort study. The Lancet Psychiatry 9 (9), pp.715-724. (10.1016/S2215-0366(22)00207-3)
Wren, G. et al. 2022. Mood symptoms, neurodevelopmental traits, and their contributory factors in X-linked ichthyosis, ichthyosis vulgaris and psoriasis. Clinical and Experimental Dermatology 47 (6), pp.1097-1108. (10.1111/ced.15116)
Wren, G. H. and Davies, W. 2022. X-linked ichthyosis: New insights into a multi-system disorder. Skin Health and Disease 2 (4) e179. (10.1002/ski2.179)
Zheng, G. et al., 2022. A transformer-based multi-features fusion model for prediction of conversion in mild cognitive impairment. Methods 205 , pp.241-248. (10.1016/j.ymeth.2022.04.015)